Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A
FBIOP
Get informed when a big investor buys or sells
+ FollowMarket Cap$131.03M
Close$
$-3.09
118.6% downside
Current Fair Value
118.6% downsideOvervalued by 118.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $131.03 Million |
|---|---|
| Enterprise Value | $-7,047,299.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.07 |
| Beta | 1.21 |
| Outstanding Shares | 31,666,585 |
Return
| Return on Equity | 64.01% |
|---|---|
| Return on Assets | 33.17% |
| Return on Invested Capital | -15.70% |
Valuation & Multiples
| P/E Ratio | 0.7 |
|---|---|
| PEG | -0.68 |
| Price to Sales | 8.34 |
| Price to Book Ratio | 2.78 |
| Enterprise Value to Revenue | -0.1 |
| Enterprise Value to EBIT | 0.18 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -8.3 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 17, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$18.30 M
Average shareholder expectationNext Earnings Call
Expected Date
November 16, 2026
EPS Estimate
$-0.27
Average shareholder expectationRevenue Estimate
$21.57 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fortress Biotech Inc
111 employees
CEO: Lindsay Rosenwald